Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1988-06-28
1990-04-24
Lipovsky, Joseph A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514178, 514179, 514182, 514181, 552539, 552526, 552515, 552561, 552588, 552587, 552583, 552600, 552601, 552602, C07J 100, A61K 3156
Patent
active
049201140
ABSTRACT:
19-Fluoro- and cyano- substituted 21-hydroxyprogesterone derivatives and related compounds which are active as 19-hydroxylase inhibitors and useful as antihypertensive agents are described herein. The compounds are prepared using appropriate synthetic pathways which will vary according to the nature of the specific 19-substituted progesterone or related compound desired.
REFERENCES:
patent: 3124574 (1964-03-01), Bowers
patent: 3154569 (1964-10-01), Ercoli et al.
patent: 3159620 (1964-12-01), Ercoli et al.
patent: 3186988 (1965-06-01), Bowers
patent: 3214427 (1965-10-01), Ercoli et al.
patent: 3257389 (1966-06-01), Bowers
patent: 3257435 (1966-06-01), Bowers et al.
patent: 3394128 (1968-07-01), Edwards
Holbert Gene W.
Johnston J. O'Neal
Kolano John J.
Lipovsky Joseph A.
Merrell Dow Pharmaceuticals Inc.
LandOfFree
19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-34869